Biocentis

Biocentis

We are a biotechnology company developing ground-breaking solutions to control the world’s most dangerous insect species

Founded 2022 Italy

Italy 18 employees Seed Total: $3.00M Agriculture, Biotechnology +2

Biocentis is a biotechnology company founded in 2021 with headquarters in Italy. The company's slogan "We are a biotechnology company developing ground-breaking solutions to control the world’s most dangerous insect species" reflects its commitment to innovating in the Agriculture, Biotechnology, and Health Care industries. Biocentis is focused on developing eco-friendly genetic solutions to effectively and safely control dangerous insect species that spread disease, reduce biodiversity, or threaten food security. The company leverages CRISPR to develop self-limiting gene drive technologies that are biological, environmentally friendly, and customizable for various applications. Biocentis aims to reimagine the future of biocontrol through its unique proprietary technological platform applicable to all insect species. Impressively, Biocentis secured its Seed Round investment on 01 February 2023 with support from Neurone and Global Agri-Food Advancement Partnership. This investment signifies the market's confidence in the company's potential to revolutionize insect control. With significant accomplishments and a fast-growing team, Biocentis is poised for further success and is seeking individuals who want to be part of its journey to contribute to a more sustainable world, capable of feeding a growing population and free of vector-borne disease.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	€3.00M	1	Neurone	13 Feb 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

€3.00M

Neurone

13 Feb 2022

FAQ About Biocentis

We are a biotechnology company developing ground-breaking solutions to control the world’s most dangerous insect species

Biocentis was founded in 2022.

Biocentis is headquartered in Italy.

Biocentis operates in Agriculture, Biotechnology, Health Care and AgriTech. Its work centres on Genetic solutions, CRISPR, Gene editing and Vector control.

Biocentis has approximately 18 employees.

Biocentis has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.

Top alternatives and competitors to Biocentis include Oxitec, Bio Controle - Métodos de Controle de Pragas Ltda, ENTOINNOV, Evolution Biotechnologies, Agriodor . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Biocentis and Oxitec are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Biocentis

Funding Rounds & Investors (1)

Biocentis Alternatives & Competitors

FAQ About Biocentis